219 related articles for article (PubMed ID: 26054784)
21. Immunohistochemical expression analysis of leucine-rich PPR-motif-containing protein (LRPPRC), a candidate colorectal cancer biomarker identified by shotgun proteomics using iTRAQ.
Nishio T; Kurabe N; Goto-Inoue N; Nakamura T; Sugimura H; Setou M; Maekawa M
Clin Chim Acta; 2017 Aug; 471():276-282. PubMed ID: 28622966
[TBL] [Abstract][Full Text] [Related]
22. Label-free quantitative mass spectrometry reveals a panel of differentially expressed proteins in colorectal cancer.
Fan NJ; Gao JL; Liu Y; Song W; Zhang ZY; Gao CF
Biomed Res Int; 2015; 2015():365068. PubMed ID: 25699276
[TBL] [Abstract][Full Text] [Related]
23. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
[TBL] [Abstract][Full Text] [Related]
24. Decreased expression of SCUBE2 is associated with progression and prognosis in colorectal cancer.
Song Q; Li C; Feng X; Yu A; Tang H; Peng Z; Wang X
Oncol Rep; 2015 Apr; 33(4):1956-64. PubMed ID: 25672935
[TBL] [Abstract][Full Text] [Related]
25. Serum proteome analysis for profiling protein markers associated with lymph node metastasis in colorectal carcinoma.
Zhao L; Liu Y; Sun X; Peng K; Ding Y
J Comp Pathol; 2011; 144(2-3):187-94. PubMed ID: 21074777
[TBL] [Abstract][Full Text] [Related]
26. Quantitative proteomic and genomic profiling reveals metastasis-related protein expression patterns in gastric cancer cells.
Chen YR; Juan HF; Huang HC; Huang HH; Lee YJ; Liao MY; Tseng CW; Lin LL; Chen JY; Wang MJ; Chen JH; Chen YJ
J Proteome Res; 2006 Oct; 5(10):2727-42. PubMed ID: 17022644
[TBL] [Abstract][Full Text] [Related]
27. Tissue-based proteomics reveals FXYD3, S100A11 and GSTM3 as novel markers for regional lymph node metastasis in colon cancer.
Meding S; Balluff B; Elsner M; Schöne C; Rauser S; Nitsche U; Maak M; Schäfer A; Hauck SM; Ueffing M; Langer R; Höfler H; Friess H; Rosenberg R; Walch A
J Pathol; 2012 Dec; 228(4):459-70. PubMed ID: 22430872
[TBL] [Abstract][Full Text] [Related]
28. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
[TBL] [Abstract][Full Text] [Related]
29. Promotion of colorectal cancer growth and metastasis by the LIM and SH3 domain protein 1.
Zhao L; Wang H; Liu C; Liu Y; Wang X; Wang S; Sun X; Li J; Deng Y; Jiang Y; Ding Y
Gut; 2010 Sep; 59(9):1226-35. PubMed ID: 20660701
[TBL] [Abstract][Full Text] [Related]
30. Global-scale profiling of differential expressed lysine acetylated proteins in colorectal cancer tumors and paired liver metastases.
Shen Z; Wang B; Luo J; Jiang K; Zhang H; Mustonen H; Puolakkainen P; Zhu J; Ye Y; Wang S
J Proteomics; 2016 Jun; 142():24-32. PubMed ID: 27178108
[TBL] [Abstract][Full Text] [Related]
31. Up-regulation of collagen proteins in colorectal liver metastasis compared with normal liver tissue.
van Huizen NA; Coebergh van den Braak RRJ; Doukas M; Dekker LJM; IJzermans JNM; Luider TM
J Biol Chem; 2019 Jan; 294(1):281-289. PubMed ID: 30409905
[TBL] [Abstract][Full Text] [Related]
32. Mapping the Spatial Proteome of Metastatic Cells in Colorectal Cancer.
Mendes M; Peláez-García A; López-Lucendo M; Bartolomé RA; Calviño E; Barderas R; Casal JI
Proteomics; 2017 Oct; 17(19):. PubMed ID: 28861940
[TBL] [Abstract][Full Text] [Related]
33. Proteomic-based identification of the APC-binding protein EB1 as a candidate of novel tissue biomarker and therapeutic target for colorectal cancer.
Sugihara Y; Taniguchi H; Kushima R; Tsuda H; Kubota D; Ichikawa H; Sakamoto K; Nakamura Y; Tomonaga T; Fujita S; Kondo T
J Proteomics; 2012 Sep; 75(17):5342-55. PubMed ID: 22735596
[TBL] [Abstract][Full Text] [Related]
34. Web-based data warehouse on gene expression in human colorectal cancer.
Sagynaliev E; Steinert R; Nestler G; Lippert H; Knoch M; Reymond MA
Proteomics; 2005 Aug; 5(12):3066-78. PubMed ID: 16041676
[TBL] [Abstract][Full Text] [Related]
35. Proteome biology of primary colorectal carcinoma and corresponding liver metastases.
Fahrner M; Bronsert P; Fichtner-Feigl S; Jud A; Schilling O
Neoplasia; 2021 Dec; 23(12):1240-1251. PubMed ID: 34768110
[TBL] [Abstract][Full Text] [Related]
36. Large scale systematic proteomic quantification from non-metastatic to metastatic colorectal cancer.
Yin X; Zhang Y; Guo S; Jin H; Wang W; Yang P
Sci Rep; 2015 Jul; 5():12120. PubMed ID: 26175278
[TBL] [Abstract][Full Text] [Related]
37. Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression.
Chen DL; Wang ZQ; Zeng ZL; Wu WJ; Zhang DS; Luo HY; Wang F; Qiu MZ; Wang DS; Ren C; Wang FH; Chiao LJ; Pelicano H; Huang P; Li YH; Xu RH
Hepatology; 2014 Aug; 60(2):598-609. PubMed ID: 24616020
[TBL] [Abstract][Full Text] [Related]
38. Colorectal cancer candidate biomarkers identified by tissue secretome proteome profiling.
de Wit M; Kant H; Piersma SR; Pham TV; Mongera S; van Berkel MP; Boven E; Pontén F; Meijer GA; Jimenez CR; Fijneman RJ
J Proteomics; 2014 Mar; 99():26-39. PubMed ID: 24418523
[TBL] [Abstract][Full Text] [Related]
39. Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa.
Bianchini M; Levy E; Zucchini C; Pinski V; Macagno C; De Sanctis P; Valvassori L; Carinci P; Mordoh J
Int J Oncol; 2006 Jul; 29(1):83-94. PubMed ID: 16773188
[TBL] [Abstract][Full Text] [Related]
40. The SOX17/miR-371-5p/SOX2 axis inhibits EMT, stem cell properties and metastasis in colorectal cancer.
Li Y; Lv Z; He G; Wang J; Zhang X; Lu G; Ren X; Wang F; Zhu X; Ding Y; Liao W; Ding Y; Liang L
Oncotarget; 2015 Apr; 6(11):9099-112. PubMed ID: 25868860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
